Sotera Health (SHC) Stock Forecast & Price Target

Compare

186 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

SHC Analyst Ratings

Moderate Buy

3 Buy

3 Hold

0 Sell

Based on 6 analysts giving stock ratings to

Sotera

Health

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

SHC Stock 12 Month Forecast

Average Price Target

$18.60

▲(18.17% Upside)

Based on 6 Wall Street analysts offering 12 month price targets for Sotera Health in the last 3 months. The average price target is $18.60 with a high forecast of $21.00 and a low forecast of $16.00. The average price target represents a 18.17% change from the last price of $15.74.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"10":"$10","13":"$13","16":"$16","19":"$19","22":"$22"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":21,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$21.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":18.6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$18.60</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":16,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$16.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[10,13,16,19,22],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Nov<br/>2025","25":"Nov<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.6,16.93846153846154,17.27692307692308,17.615384615384617,17.953846153846154,18.292307692307695,18.630769230769232,18.96923076923077,19.307692307692307,19.646153846153847,19.984615384615385,20.323076923076925,20.661538461538463,{"y":21,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.6,16.753846153846155,16.907692307692308,17.06153846153846,17.215384615384618,17.36923076923077,17.523076923076925,17.676923076923078,17.83076923076923,17.984615384615385,18.13846153846154,18.292307692307695,18.446153846153848,{"y":18.6,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.6,16.553846153846155,16.50769230769231,16.461538461538463,16.415384615384617,16.36923076923077,16.323076923076925,16.276923076923076,16.23076923076923,16.184615384615384,16.138461538461538,16.092307692307692,16.046153846153846,{"y":16,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":16.27,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.86,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.25,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.68,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.71,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.47,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.13,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.1,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.19,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.45,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.15,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.19,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.6,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$21.00

Average Price Target$18.60

Lowest Price Target$16.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Luke Sergott

Barclays

$20

Buy

27.06%

Upside

Reiterated

11/24/25

Barclays Reaffirms Their Buy Rating on Sotera Health (SHC)

David Windley

Jefferies

$19.5

Buy

23.89%

Upside

Reiterated

11/20/25

Jefferies Keeps Their Buy Rating on Sotera Health (SHC)

Sean Dodge

BMO Capital

$19

Buy

20.71%

Upside

Initiated

11/12/25

BMO Capital's Buy Rating on Sotera Health: Positive Outlook Amid Growth Resurgence and Strategic Strengths

Casey Woodring

J.P. Morgan

$14→$16

Hold

1.65%

Upside

Reiterated

11/05/25

J.P. Morgan Sticks to Its Hold Rating for Sotera Health (SHC)

Brett Fishbin

KeyBanc

―

Hold

―

Reiterated

11/05/25

Sotera Health (SHC) Receives a Hold from KeyBanc

Jason Bednar

Piper Sandler

$15→$17

Hold

8.01%

Upside

Reiterated

11/05/25

Sotera Health price target raised to $17 from $15 at Piper SandlerSotera Health price target raised to $17 from $15 at Piper Sandler

Unknown Analyst

Citi

Not Ranked

Citi

$21

Buy

33.42%

Upside

Reiterated

10/07/25

Citi Keeps Their Buy Rating on Sotera Health (SHC)We rate SHC Buy/High Risk (1H). Our $21 target price applies a 12.5x EV/EBITDA multiple to our Q5-Q8 EBITDA estimate of $638mn.

Michael Polark

Wolfe Research

$16→$17

Buy

8.01%

Upside

Reiterated

08/08/25

Wolfe Research Sticks to Its Buy Rating for Sotera Health (SHC)

Matthew Sykes

Goldman Sachs

$17

Buy

8.01%

Upside

Upgraded

05/05/25

Sotera Health: Resilient Growth and Strategic Positioning Amidst Economic Challenges

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Luke Sergott

Barclays

$20

Buy

27.06%

Upside

Reiterated

11/24/25

Barclays Reaffirms Their Buy Rating on Sotera Health (SHC)

David Windley

Jefferies

$19.5

Buy

23.89%

Upside

Reiterated

11/20/25

Jefferies Keeps Their Buy Rating on Sotera Health (SHC)

Sean Dodge

BMO Capital

$19

Buy

20.71%

Upside

Initiated

11/12/25

BMO Capital's Buy Rating on Sotera Health: Positive Outlook Amid Growth Resurgence and Strategic Strengths

Casey Woodring

J.P. Morgan

$14→$16

Hold

1.65%

Upside

Reiterated

11/05/25

J.P. Morgan Sticks to Its Hold Rating for Sotera Health (SHC)

Brett Fishbin

KeyBanc

―

Hold

―

Reiterated

11/05/25

Sotera Health (SHC) Receives a Hold from KeyBanc

Jason Bednar

Piper Sandler

$15→$17

Hold

8.01%

Upside

Reiterated

11/05/25

Sotera Health price target raised to $17 from $15 at Piper SandlerSotera Health price target raised to $17 from $15 at Piper Sandler

Unknown Analyst

Citi

Not Ranked

Citi

$21

Buy

33.42%

Upside

Reiterated

10/07/25

Citi Keeps Their Buy Rating on Sotera Health (SHC)We rate SHC Buy/High Risk (1H). Our $21 target price applies a 12.5x EV/EBITDA multiple to our Q5-Q8 EBITDA estimate of $638mn.

Michael Polark

Wolfe Research

$16→$17

Buy

8.01%

Upside

Reiterated

08/08/25

Wolfe Research Sticks to Its Buy Rating for Sotera Health (SHC)

Matthew Sykes

Goldman Sachs

$17

Buy

8.01%

Upside

Upgraded

05/05/25

Sotera Health: Resilient Growth and Strategic Positioning Amidst Economic Challenges

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sotera Health

1 Month

xxx

Success Rate

12/21 ratings generated profit

Average Return

+1.47%

initiated a xxx

rating 23 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 57.14% of your transactions generating a profit, with an average return of +1.47% per trade.

3 Months

xxx

Success Rate

13/27 ratings generated profit

Average Return

-7.37%

reiterated a xxx

rating 11 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 48.15% of your transactions generating a profit, with an average return of -7.37% per trade.

1 Year

Luke SergottBarclays

Success Rate

8/27 ratings generated profit

Average Return

-10.01%

reiterated a buy rating 11 days ago

Copying Luke Sergott's trades and holding each position for 1 Year would result in 29.63% of your transactions generating a profit, with an average return of -10.01% per trade.

2 Years

xxx

Success Rate

12/27 ratings generated profit

Average Return

-3.93%

reiterated a xxx

rating 11 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 44.44% of your transactions generating a profit, with an average return of -3.93% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SHC Analyst Recommendation Trends

Rating

Jun 25

Jul 25

Aug 25

Oct 25

Nov 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, SHC has received 9 Buy Ratings, 10 Hold Ratings, and 0 Sell Ratings. SHC average Analyst price target in the past 3 months is 18.60.

Each month's total comprises the sum of three months' worth of ratings.

SHC Financial Forecast

SHC Earnings Forecast

Next quarter’s earnings estimate for SHC is $0.24 with a range of $0.24 to $0.25. The previous quarter’s EPS was $0.26. SHC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year SHC has Performed in-line its overall industry.

SHC Sales Forecast

Next quarter’s sales forecast for SHC is $299.17M with a range of $298.00M to $299.90M. The previous quarter’s sales results were $311.31M. SHC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year SHC has Performed in-line its overall industry.

SHC Stock Forecast FAQ

What is SHC’s average 12-month price target, according to analysts?

Based on analyst ratings, Sotera Health Company’s 12-month average price target is 18.60.

What is SHC’s upside potential, based on the analysts’ average price target?

Sotera Health Company has 18.17% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is SHC a Buy, Sell or Hold?

Sotera Health Company has a consensus rating of Moderate Buy which is based on 3 buy ratings, 3 hold ratings and 0 sell ratings.

What is Sotera Health Company’s price target?

The average price target for Sotera Health Company is 18.60. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $21.00 ,the lowest forecast is $16.00. The average price target represents 18.17% Increase from the current price of $15.74.

What do analysts say about Sotera Health Company?

Sotera Health Company’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 6 Wall Streets Analysts.

How can I buy shares of SHC?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Sotera Health (SHC) Stock Forecast & Price Target

SHC Analyst Ratings

SHC Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Sotera Health

SHC Analyst Recommendation Trends

SHC Financial Forecast

SHC Earnings Forecast

SHC Sales Forecast

SHC Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts